Published: January 31st 2024 | Updated: May 9th 2024
How biosimilars expand treatment options for patients with retinal disease
Published: September 20th 2024 | Updated: September 28th 2024
EURETINA 2024: Andrea Govetto, MD, PhD, says it takes teamwork to understand macular oedema
Published: September 19th 2024 | Updated: September 28th 2024
Johnson & Johnson Vision supports EC survey on potential electronic Instructions for Use expansion
Published: September 9th 2024 | Updated: September 28th 2024
Remembering a legend: EURETINA members speak about the Ramin Tadayoni Award
Published: September 11th 2024 | Updated: September 28th 2024
Industry preview: Ophthalmic companies bring updates, new research findings to EURETINA
Published: September 6th 2024 | Updated: September 28th 2024
ESCRS 2024: 36-month results following femtosecond laser image-guided high precision trabeculotomy (FLigHT)